Meta-analyses involving cross-over trials: methodological issues DR Elbourne, DG Altman, JPT Higgins, F Curtin, HV Worthington, A Vail International journal of epidemiology 31 (1), 140-149, 2002 | 1702 | 2002 |
Mortality at 12 and 24 months after stroke may be associated with depressive symptoms at 1 month A House, P Knapp, J Bamford, A Vail Stroke 32 (3), 696-701, 2001 | 648 | 2001 |
The people risks M Smith Computer Law & Security Review 4 (6), 2-6, 1989 | 615 | 1989 |
Detection of atrial fibrillation after ischemic stroke or transient ischemic attack: a systematic review and meta-analysis A Kishore, A Vail, A Majid, J Dawson, KR Lees, PJ Tyrrell, CJ Smith stroke 45 (2), 520-526, 2014 | 576 | 2014 |
A randomised phase II study of interleukin-1 receptor antagonist in acute stroke patients HCA Emsley, CJ Smith, RF Georgiou, A Vail, SJ Hopkins, NJ Rothwell, ... Journal of Neurology, Neurosurgery & Psychiatry 76 (10), 1366-1372, 2005 | 556 | 2005 |
Barrier agents for adhesion prevention after gynaecological surgery G Ahmad, K Kim, M Thompson, P Agarwal, H O'Flynn, A Hindocha, ... Cochrane Database of Systematic Reviews, 2020 | 476 | 2020 |
Infant wellbeing at 2 years of age in the Growth Restriction Intervention Trial (GRIT): multicentred randomised controlled trial GRIT Study Group The Lancet 364 (9433), 513-520, 2004 | 461 | 2004 |
Randomised controlled trial of clinical medication review by a pharmacist of elderly patients receiving repeat prescriptions in general practice AG Zermansky, DR Petty, DK Raynor, N Freemantle, A Vail, CJ Lowe Bmj 323 (7325), 1340, 2001 | 434 | 2001 |
Diagnosis of stroke-associated pneumonia: recommendations from the pneumonia in stroke consensus group CJ Smith, AK Kishore, A Vail, A Chamorro, J Garau, SJ Hopkins, ... Stroke 46 (8), 2335-2340, 2015 | 419 | 2015 |
How practical are recommendations for dietary control in phenylketonuria? JH Walter, FJ White, SK Hall, A MacDonald, G Rylance, A Boneh, ... The Lancet 360 (9326), 55-57, 2002 | 398 | 2002 |
An early and sustained peripheral inflammatory response in acute ischaemic stroke: relationships with infection and atherosclerosis HCA Emsley, CJ Smith, CM Gavin, RF Georgiou, A Vail, EM Barberan, ... Journal of neuroimmunology 139 (1-2), 93-101, 2003 | 379 | 2003 |
Design, analysis, and presentation of crossover trials EJ Mills, AW Chan, P Wu, A Vail, GH Guyatt, DG Altman Trials 10, 1-6, 2009 | 361 | 2009 |
The Social Communication Intervention Project: a randomized controlled trial of the effectiveness of speech and language therapy for school‐age children who have pragmatic and … C Adams, E Lockton, J Freed, J Gaile, G Earl, K McBean, M Nash, J Green, ... International Journal of Language & Communication Disorders 47 (3), 233-244, 2012 | 346 | 2012 |
Ten year follow up of ulcerative colitis patients with and without low grade dysplasia CH Lim, MF Dixon, A Vail, D Forman, DAF Lynch, ATR Axon Gut 52 (8), 1127-1132, 2003 | 285 | 2003 |
Recombinant versus urinary gonadotrophin for ovarian stimulation in assisted reproductive technology cycles M van Wely, I Kwan, AL Burt, J Thomas, A Vail, F Van der Veen, ... Cochrane Database of Systematic Reviews, 2011 | 251 | 2011 |
Mortality from melanoma in migrants to Australia: variation by age at arrival and duration of stay M Khlat, A Vail, M Parkin, A Green American journal of epidemiology 135 (10), 1103-1113, 1992 | 247 | 1992 |
Brain inflammation is induced by co-morbidities and risk factors for stroke C Drake, H Boutin, MS Jones, A Denes, BW McColl, JR Selvarajah, ... Brain, behavior, and immunity 25 (6), 1113-1122, 2011 | 236 | 2011 |
The role of sunlight exposure in determining the vitamin D status of the UK white adult population AR Webb, R Kift, MT Durkin, SJ O’brien, A Vail, JL Berry, LE Rhodes British Journal of Dermatology 163 (5), 1050-1055, 2010 | 228 | 2010 |
Conclusions of the corneal transplant follow up study A Vail, SM Gore, BA Bradley, DL Easty, CA Rogers, WJ Armitage British Journal of Ophthalmology 81 (8), 631-636, 1997 | 215 | 1997 |
Recommended summer sunlight exposure levels can produce sufficient (≥ 20 ng ml− 1) but not the proposed optimal (≥ 32 ng ml− 1) 25 (OH) D levels at UK latitudes LE Rhodes, AR Webb, HI Fraser, R Kift, MT Durkin, D Allan, SJ O'brien, ... Journal of Investigative Dermatology 130 (5), 1411-1418, 2010 | 212 | 2010 |